DDDanielle DiMezza

Danielle DiMezza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Danielle DiMezza has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Noise Reduction in Photoplethysmography Signals Using a Convolutional Denoising Autoencoder With Unconventional Training Scheme

    by Fahimeh Mohagheghian, Dong Han, Om Ghetia, Andrew Peitzsch, Nishat Nishita, Mahdi Pirayesh Shirazi Nejad, Eric Y. Ding, Kamran Noorishirazi, Alexander Hamel, Edith Mensah Otabil, et al.

    Objective: We propose an efficient approach based on a convolutional denoising autoencoder (CDA) network to reduce motion and noise artifacts (MNA) from corrupted atrial fibrillation (AF) and non-AF photoplethysmography (PPG) data segments so that an accurate PPG-signal-derived heart rate can be obtained. Our method's main innovation is the optimization of the CDA performance for both rhythms using more AF than non-AF data for training the AF-specific CDA model and vice versa for the non-AF CDA network. Methods: To evaluate this unconventional training scheme, our proposed network was trained and tested on 25-sec PPG data segments from 48 subjects from two different databases–the Pulsewatch dataset and Stanford University's publicly available PPG dataset. In total, our dataset contains 10,773 data segments: 7,001 segments for training and 3,772 independent segments from out-of-sample subjects for testing. Results: Using real-life corrupted PPG segments, our approach significantly reduced the average heart rate root mean square error (RMSE) of the reconstructed PPG segments by 45.74% and 23% compared to the corrupted non-AF and AF data, respectively. Further, our approach exhibited lower RMSE, and higher sensitivity and PPV for detected peaks compared to the reconstructed data produced by the alternative methods. Conclusion: These results show the promise of our approach as a reliable denoising method, which should be used prior to AF detection algorithms for an accurate cardiac health monitoring involving wearable devices. Significance: PPG signals collected from wearables are vulnerable to MNA, which limits their use as a reliable measurement, particularly in uncontrolled real-life environments.


  • Open Access

    A Smartwatch System for Continuous Monitoring of Atrial Fibrillation in Older Adults After Stroke or Transient Ischemic Attack: Application Design Study

    by Dong Han, Eric Y Ding, Chaeho Cho, Haewook Jung, Emily L Dickson, Fahimeh Mohagheghian, Andrew G Peitzsch, Danielle DiMezza, Khanh-Van Tran, David D McManus, et al.

    Background: The prevalence of atrial fibrillation (AF) increases with age and can lead to stroke. Therefore, older adults may benefit the most from AF screening. However, older adult populations tend to lag more than younger groups in the adoption of, and comfort with, the use of mobile health (mHealth) apps. Furthermore, although mobile apps that can detect AF are available to the public, most are designed for intermittent AF detection and for younger users. No app designed for long-term AF monitoring has released detailed system design specifications that can handle large data collections, especially in this age group. Objective: This study aimed to design an innovative smartwatch-based AF monitoring mHealth solution in collaboration with older adult participants and clinicians. Methods: The Pulsewatch system is designed to link smartwatches and smartphone apps, a website for data verification, and user data organization on a cloud server. The smartwatch in the Pulsewatch system is designed to continuously monitor the pulse rate with embedded AF detection algorithms, and the smartphone in the Pulsewatch system is designed to serve as the data-transferring hub to the cloud storage server. Results: We implemented the Pulsewatch system based on the functionality that patients and caregivers recommended. The user interfaces of the smartwatch and smartphone apps were specifically designed for older adults at risk for AF. We improved our Pulsewatch system based on feedback from focus groups consisting of patients with stroke and clinicians. The Pulsewatch system was used by the intervention group for up to 6 weeks in the 2 phases of our randomized clinical trial. At the conclusion of phase 1, 90 trial participants who had used the Pulsewatch app and smartwatch for 14 days completed a System Usability Scale to assess the usability of the Pulsewatch system; of 88 participants, 56 (64%) endorsed that the smartwatch app is “easy to use.” For phases 1 and 2 of the study, we collected 9224.4 hours of smartwatch recordings from the participants. The longest recording streak in phase 2 was 21 days of consecutive recordings out of the 30 days of data collection. Conclusions: This is one of the first studies to provide a detailed design for a smartphone-smartwatch dyad for ambulatory AF monitoring. In this paper, we report on the system’s usability and opportunities to increase the acceptability of mHealth solutions among older patients with cognitive impairment. Trial Registration: ClinicalTrials.gov NCT03761394; https://www.clinicaltrials.gov/ct2/show/NCT03761394 International Registered Report Identifier (IRRID): RR2-10.1016/j.cvdhj.2021.07.002


  • Open Access

    Pulsewatch: A Smartwatch System Designed with Stroke Survivors for Continuous Monitoring of Atrial Fibrillation in Older Adults after Stroke or Transient Ischemic Attack (Preprint)

    by Dong Han, Eric Y Ding, Chaeho Cho, Haewook Jung, Emily L Dickson, Fahimeh Mohagheghian, Andrew Peitzsch, Danielle DiMezza, Khanh-Van Tran, David D McManus, et al.

    BACKGROUND Atrial fibrillation (AF) prevalence increases with age and may lead to stroke. Therefore, older adults are a group that may benefit most from AF screening. Yet older adult populations tend to lag younger groups in terms of adoption of, and comfort with, the use of mobile health applications. Furthermore, although mobile apps that can detect AF are available to the public, most of them are designed for intermittent AF detection and for younger users. No app designed for long-term AF monitoring has released detailed system design specifications that can handle especially large data collection, especially in this age group. OBJECTIVE In collaboration with AF patients and their medical providers, this study aimed to design an innovative smartwatch-based AF monitoring mHealth solution for the older adult population. METHODS Based on functionality that patients and caregivers suggested, we designed the Pulsewatch system. The resulting system consisted of linked smartwatch and smartphone applications, a website for data verification, and user data organization on a cloud server. The smartwatch in the Pulsewatch system continuously monitored the pulse rate with embedded AF detection algorithms, and the smartphone in the Pulsewatch system serves as the data transferring hub to our cloud storage server. The user interface of the smartwatch and smartphone apps were specifically designed for older adults at risk for AF. We improved our Pulsewatch system based on the feedback from focus groups consisting of stroke patients and healthcare providers. The Pulsewatch system was used by the intervention group for up to 6 weeks in the two Phases of our randomized clinical trial (NCT03761394). RESULTS At the conclusion of Phase 1, 90 trial participants who had used Pulsewatch app and smartwatch for 14 days completed a System Usability Scale (SUS) to assess the usability of the Pulsewatch system; 64% of participants endorsed that the smartwatch app is “easy to use.” For Phases 1 and 2 of the study, we collected 9224.4 hours of watch recordings from participants. The longest recording streak in Phase 2 was 21 days of consecutive recording out of the 30 days of data collection. CONCLUSIONS This is one of the first studies to provide a detailed design for a smartphone-smartwatch dyad for ambulatory AF monitoring. In it, we report on the system’s usability and opportunities to increase the acceptability of mHealth solutions among older patients with cognitive impairment. CLINICALTRIAL ClinicalTrials.gov NCT03761394 INTERNATIONAL REGISTERED REPORT RR2-10.1016/j.cvdhj.2021.07.002

  • Open Access

    Understanding Healthcare Professionals’ Perspectives on Point-of-Care Testing

    by Sean Teebagy, Ziyue Wang, Denise Dunlap, Connor Saleeba, Danielle DiMezza, JoAnn Crain, Craig M. Lilly, Bryan Buchholz, David D. McManus, Nathaniel Hafer

    Point-of-care testing (POCT) is an emerging technology that provides crucial assistance in delivering healthcare. The COVID-19 pandemic led to the accelerated importance of POCT technology due to its in-home accessibility. While POCT use and implementation has increased, little research has been published about how healthcare professionals perceive these technologies. The objective of our study was to examine the current perspectives of healthcare professionals towards POCT. We surveyed healthcare professionals to quantify perceptions of POCT usage, adoption, benefits, and concerns between October 2020 and November 2020. Questions regarding POCT perception were assessed on a 5-point Likert Scale. We received a total of 287 survey responses. Of the respondents, 53.7% were male, 66.6% were white, and 30.7% have been in practice for over 20 years. We found that the most supported benefit was POCTs ability to improve patient management (92%) and that the most supported concern was that POCTs lead to over-testing (30%). This study provides a better understanding of healthcare workers’ perspectives on POCT. To improve patient outcomes through the usage of POCT, greater research is needed to assess the needs and concerns of industry and healthcare stakeholders.


  • Open Access

    A Real-Time PPG Peak Detection Method for Accurate Determination of Heart Rate during Sinus Rhythm and Cardiac Arrhythmia

    by Dong Han, Syed Khairul Bashar, Jesús Lázaro, Fahimeh Mohagheghian, Andrew Peitzsch, Nishat Nishita, Eric Ding, Emily L. Dickson, Danielle DiMezza, Jessica Scott, et al.

    Objective: We have developed a peak detection algorithm for accurate determination of heart rate, using photoplethysmographic (PPG) signals from a smartwatch, even in the presence of various cardiac rhythms, including normal sinus rhythm (NSR), premature atrial contraction (PAC), premature ventricle contraction (PVC), and atrial fibrillation (AF). Given the clinical need for accurate heart rate estimation in patients with AF, we developed a novel approach that reduces heart rate estimation errors when compared to peak detection algorithms designed for NSR. Methods: Our peak detection method is composed of a sequential series of algorithms that are combined to discriminate the various arrhythmias described above. Moreover, a novel Poincaré plot scheme is used to discriminate between basal heart rate AF and rapid ventricular response (RVR) AF, and to differentiate PAC/PVC from NSR and AF. Training of the algorithm was performed only with Samsung Simband smartwatch data, whereas independent testing data which had more samples than did the training data were obtained from Samsung’s Gear S3 and Galaxy Watch 3. Results: The new PPG peak detection algorithm provides significantly lower average heart rate and interbeat interval beat-to-beat estimation errors—30% and 66% lower—and mean heart rate and mean interbeat interval estimation errors—60% and 77% lower—when compared to the best of the seven other traditional peak detection algorithms that are known to be accurate for NSR. Our new PPG peak detection algorithm was the overall best performers for other arrhythmias. Conclusion: The proposed method for PPG peak detection automatically detects and discriminates between various arrhythmias among different waveforms of PPG data, delivers significantly lower heart rate estimation errors for participants with AF, and reduces the number of false negative peaks. Significance: By enabling accurate determination of heart rate despite the presence of AF with rapid ventricular response or PAC/PVCs, we enable clinicians to make more accurate recommendations for heart rate control from PPG data.


  • Open Access

    Patient Preferences for Point-of-Care Testing

    by Craig M. Lilly, Emily Bs Ensom, Sean Ba Teebagy, Danielle BA DiMezza, Denise Dunlap, Nathaniel Hafer, Bryan Buchholz, David MD McManus

    Background Studies of current opinion of our community members for the characteristics, mode, and location of use, use cases, and overall enthusiasm for point-of-care testing (POCT) diagnosis and management tools are needed. Study Design and Methods Qualitative research methods were used to develop, refine, and evaluate hardcopy and electronic versions of a 45-item English language survey. The accuracy of the instrument was measured by recorded structured interview, and its precision was measured by comparison to its administration to a group of uncompensated volunteers. Main Findings and Results Comparison of survey and structured interview data demonstrated high levels of accuracy. Highly concordant with significant levels of correlation and of direct association indicated favorable precision. Ninety-three percent of respondents believed that POCT could improve their care, and 56% identified having a POCT in their home as a top priority. Accuracy, insurance coverage, immediacy of results, and ease of use were identified as the most important characteristics of a POCT. Conclusions Community members strongly support the development of accurate, in-home devices that produce immediate results that can be used to diagnose, manage, and encourage their adherence to treatments for their medical conditions.